Abbott Laboratories - 36 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of December 09, 2019 is 83.87.
- The all-time high Abbott Laboratories stock closing price was 88.74 on July 23, 2019.
- The Abbott Laboratories 52-week high stock price is 88.76, which is 5.8% above the current share price.
- The Abbott Laboratories 52-week low stock price is 65.44, which is 22% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 79.62.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 80.1556 | 69.5000 | 88.7400 | 66.2200 | 83.8700 | 15.95% |
| 2018 | 64.2198 | 58.7900 | 74.2700 | 56.2700 | 72.3300 | 26.74% |
| 2017 | 48.5437 | 39.0500 | 57.4700 | 39.0500 | 57.0700 | 48.58% |
| 2016 | 40.4946 | 42.9300 | 45.2900 | 36.3400 | 38.4100 | -14.47% |
| 2015 | 46.3063 | 44.9000 | 51.2000 | 39.0600 | 44.9100 | -0.24% |
| 2014 | 40.9592 | 38.2300 | 46.3700 | 35.8500 | 45.0200 | 17.45% |
| 2013 | 35.6540 | 32.0500 | 38.7100 | 32.0500 | 38.3300 | -41.48% |
| 2012 | 62.7592 | 56.7200 | 72.1300 | 54.1500 | 65.5000 | 16.49% |
| 2011 | 51.0656 | 47.8200 | 56.3300 | 45.1600 | 56.2300 | 17.37% |
| 2010 | 50.7320 | 54.4600 | 56.2400 | 45.8600 | 47.9100 | -11.26% |
| 2009 | 48.4288 | 53.5600 | 57.2500 | 41.5200 | 53.9900 | 1.16% |
| 2008 | 55.1625 | 55.8100 | 60.5000 | 49.4500 | 53.3700 | -4.95% |
| 2007 | 54.4193 | 48.9700 | 59.4300 | 48.9700 | 56.1500 | 15.27% |
| 2006 | 45.0284 | 39.5500 | 49.4800 | 39.5500 | 48.7100 | 23.54% |
| 2005 | 45.3700 | 46.6700 | 49.9900 | 37.6300 | 39.4300 | -15.48% |
| 2004 | 42.3562 | 46.7500 | 46.9900 | 38.3600 | 46.6500 | 0.11% |
| 2003 | 41.2727 | 40.0500 | 47.1500 | 34.3800 | 46.6000 | 16.50% |
| 2002 | 45.8684 | 55.8400 | 57.7000 | 31.0000 | 40.0000 | -28.25% |
| 2001 | 50.0663 | 48.1300 | 56.7700 | 42.0600 | 55.7500 | 15.09% |
| 2000 | 41.6982 | 35.0000 | 55.7500 | 29.6300 | 48.4400 | 33.41% |
| 1999 | 43.6333 | 48.7500 | 52.9400 | 33.3100 | 36.3100 | -25.90% |
| 1998 | 40.9077 | 33.7200 | 49.7500 | 33.3450 | 49.0000 | 49.62% |
| 1997 | 30.8148 | 25.1900 | 34.3150 | 25.1900 | 32.7500 | 29.06% |
| 1996 | 22.6483 | 20.8750 | 28.3750 | 19.3750 | 25.3750 | 21.91% |
| 1995 | 19.2416 | 16.3150 | 22.3150 | 15.6250 | 20.8150 | 27.58% |
| 1994 | 14.8357 | 14.4400 | 16.8150 | 13.0650 | 16.3150 | 10.12% |
| 1993 | 13.4211 | 15.1900 | 15.1900 | 11.5000 | 14.8150 | -2.47% |
| 1992 | 15.3475 | 16.8125 | 17.0300 | 13.5000 | 15.1900 | -11.78% |
| 1991 | 13.0176 | 10.8125 | 17.2175 | 9.9375 | 17.2175 | 53.04% |
| 1990 | 9.5320 | 8.6563 | 11.3750 | 7.8750 | 11.2500 | 32.35% |
| 1989 | 7.3855 | 5.9688 | 8.7663 | 5.8288 | 8.5000 | 41.28% |
| 1988 | 5.8545 | 6.0788 | 6.5000 | 5.3750 | 6.0163 | -0.25% |
| 1987 | 7.1870 | 5.9375 | 8.3600 | 5.3750 | 6.0313 | 5.74% |
| 1986 | 5.4847 | 4.2500 | 6.7963 | 3.9844 | 5.7038 | 33.48% |
| 1985 | 3.4075 | 2.5394 | 4.3831 | 2.5000 | 4.2731 | 63.76% |
| 1984 | 2.6840 | 2.8750 | 3.0000 | 2.3750 | 2.6094 | -7.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $151.168B | $30.578B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $151.583B | 20.94 |
| Stryker (SYK) | United States | $76.313B | 25.66 |
| Boston Scientific (BSX) | United States | $61.440B | 29.00 |
| Baxter (BAX) | United States | $42.463B | 25.75 |
| Essilor Luxottica (ESLOY) | France | $33.468B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.550B | 19.17 |
| Terumo (TRUMY) | Japan | $27.062B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.531B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.294B | 39.03 |
| ResMed (RMD) | United States | $21.653B | 39.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.279B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.373B | 541.06 |
| Bio-Rad Laboratories (BIO) | United States | $11.201B | 53.76 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.203B | 21.24 |
| Perrigo (PRGO) | Ireland | $7.117B | 13.27 |
| Canopy Growth (CGC) | Canada | $6.501B | 0.00 |
| Haemonetics (HAE) | United States | $6.146B | 41.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| NuVasive (NUVA) | United States | $3.890B | 30.64 |
| ICU Medical (ICUI) | United States | $3.830B | 24.97 |
| Neogen (NEOG) | United States | $3.545B | 59.33 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.165B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.121B | 0.00 |
| Quidel (QDEL) | United States | $2.954B | 28.04 |
| Aurora Cannabis (ACB) | Canada | $2.648B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.432B | 54.89 |
| Agios Pharmaceuticals (AGIO) | United States | $2.411B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.577B | 0.00 |
| InMode (INMD) | Israel | $1.516B | 0.00 |
| AtriCure (ATRC) | United States | $1.226B | 0.00 |
| Aphria (APHA) | $1.187B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.162B | 23.28 |
| Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
| NanoString Technologies (NSTG) | United States | $0.944B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.802B | 20.04 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 29.55 |
| TG Therapeutics (TGTX) | United States | $0.709B | 0.00 |
| Quanterix (QTRX) | United States | $0.705B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.698B | 39.25 |
| PetIQ (PETQ) | United States | $0.675B | 16.46 |
| Omeros (OMER) | United States | $0.655B | 0.00 |
| Cerus (CERS) | United States | $0.574B | 0.00 |
| Surmodics (SRDX) | United States | $0.570B | 59.24 |
| HEXO (HEXO) | $0.537B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.492B | 29.52 |
| Owens & Minor (OMI) | United States | $0.474B | 17.53 |
| MacroGenics (MGNX) | United States | $0.474B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.396B | 28.71 |
| Meridian Bioscience (VIVO) | United States | $0.396B | 13.62 |
| BioLife Solutions (BLFS) | United States | $0.331B | 134.92 |
| Zynex (ZYXI) | United States | $0.329B | 37.22 |
| Bovie Medical (APYX) | United States | $0.275B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.269B | 0.00 |
| United Health Products (UEEC) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 25.52 |
| Vapotherm (VAPO) | United States | $0.227B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.195B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.192B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.164B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.153B | 773.00 |
| Chimerix (CMRX) | United States | $0.151B | 0.00 |
| Female Health (VERU) | United States | $0.148B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 9.03 |
| MTech Acquisition (KERN) | United States | $0.114B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 23.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| Surface Oncology (SURF) | United States | $0.062B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Myomo (MYO) | United States | $0.008B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
